The grant from The Mark Foundation for Cancer Research will establish The Mark Foundation Center for Immunotherapy, Immune Signaling, and Radiation at the University of Pennsylvania, which will seek to better understand the interconnected relationship between novel forms of radiation therapy, important signaling pathways between cancer and immune cells, and the immune system’s ability to kill cancer. Five projects will bring together multidisciplinary teams of basic science and clinical researchers to answer these key questions. Read the announcement.
New leaders will build on the momentum of the first five years Palo Alto, Calif. – Today, the Science Philanthropy […]
The Science Philanthropy Alliance announced that the John Templeton Foundation has joined the Alliance as a benefactor. Founded by the […]